搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

  1. 首頁(yè)
  2. 試劑盒
  3. 酶聯(lián)免疫試劑盒
  4. Human transgelin (TAGLN) ELISA kit

Human transgelin (TAGLN) ELISA kit

  • 中文名稱：
    人膠轉(zhuǎn)蛋白(TAGLN)酶聯(lián)免疫試劑盒
  • 貨號(hào)：
    CSB-E17844h
  • 規(guī)格：
    96T/48T
  • 價(jià)格：
    ￥3600/￥2500
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    人膠轉(zhuǎn)蛋白(TAGLN)酶聯(lián)免疫試劑盒（CSB-E17844h）為雙抗夾心法ELISA試劑盒，定量檢測(cè)血清、血漿、組織勻漿樣本中的TAGLN含量。人膠轉(zhuǎn)蛋白(TAGLN)是一種肌動(dòng)蛋白結(jié)合蛋白，屬于鈣調(diào)蛋白家族，廣泛表達(dá)于血管和內(nèi)臟平滑肌，是平滑肌分化的早期標(biāo)志。TAGLN在腫瘤中作為腫瘤抑制基因，其低表達(dá)與多種癌癥的發(fā)生發(fā)展相關(guān)，特別是在結(jié)腸癌中，其高表達(dá)可能促進(jìn)腫瘤轉(zhuǎn)移。研究TAGLN在結(jié)腸癌中的作用機(jī)制，有助于為預(yù)防和控制結(jié)腸癌轉(zhuǎn)移提供新的分子基礎(chǔ)和靶點(diǎn)。試劑盒檢測(cè)范圍為0.312 ng/mL-20 ng/mL，科研人員可利用該產(chǎn)品探究心血管疾病、器官纖維化或腫瘤微環(huán)境中TAGLN的表達(dá)調(diào)控機(jī)制，也可用于體外細(xì)胞模型或動(dòng)物實(shí)驗(yàn)的組織樣本分析，為相關(guān)分子機(jī)制研究提供可靠數(shù)據(jù)支持。試劑盒兼容常規(guī)酶標(biāo)儀檢測(cè)，適用于生命科學(xué)基礎(chǔ)研究與轉(zhuǎn)化醫(yī)學(xué)領(lǐng)域的蛋白定量需求。本品僅用于科研，不用于臨床診斷，產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說(shuō)明書。
  • 別名：
    TAGLN ELISA Kit; SM22 ELISA Kit; WS3-10 ELISA Kit; Transgelin ELISA Kit; 22 kDa actin-binding protein ELISA Kit; Protein WS3-10 ELISA Kit; Smooth muscle protein 22-alpha ELISA Kit; SM22-alpha ELISA Kit
  • 縮寫：
    TAGLN
  • Uniprot No.：
  • 種屬：
    Homo sapiens (Human)
  • 樣本類型：
    serum, plasma, tissue homogenates
  • 檢測(cè)范圍：
    0.312 ng/mL-20 ng/mL
  • 靈敏度：
    0.078 ng/mL
  • 反應(yīng)時(shí)間：
    1-5h
  • 樣本體積：
    50-100ul
  • 檢測(cè)波長(zhǎng)：
    450 nm
  • 研究領(lǐng)域：
    Others
  • 測(cè)定原理：
    quantitative
  • 測(cè)定方法：
    Sandwich
  • 精密度：
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度：
    To assess the linearity of the assay, samples were spiked with high concentrations of human TAGLN in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    SampleSerum(n=4)
    1:1Average %88
    Range %82-93
    1:2Average %101
    Range %95-105
    1:4Average %97
    Range %92-101
    1:8Average %88
    Range %83-96
  • 回收率：
    The recovery of human TAGLN spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 8581-90
    EDTA plasma (n=4)9995-102
  • 標(biāo)準(zhǔn)曲線：
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/mlOD1OD2AverageCorrected
    202.823 2.902 2.863 2.754
    102.166 2.355 2.261 2.152
    51.443 1.496 1.470 1.361
    2.51.035 1.052 1.044 0.935
    1.250.558 0.596 0.577 0.468
    0.6250.374 0.375 0.375 0.266
    0.3120.231 0.248 0.240 0.131
    00.108 0.109 0.109
  • 數(shù)據(jù)處理：
  • 貨期：
    3-5 working days

引用文獻(xiàn)

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能：
    Actin cross-linking/gelling protein. Involved in calcium interactions and contractile properties of the cell that may contribute to replicative senescence.
  • 基因功能參考文獻(xiàn)：
    1. High expression level of TAGLN is associated with prostate cancer. PMID: 26934553
    2. this study identified potential biochemical players involved in distant recurrence and indicates that R-Ras and Transgelin are potential post-surgical prognostic biomarkers for Stage III colorectal cancer PMID: 27270312
    3. During transition from the pluripotent stage towards the neural developmental stage, TAGLN is differentially expressed in bipolar patient derived cells compared to control derived cells. PMID: 28117838
    4. Data (including data from studies using cells cultured from transgenic/knockout mice) suggest that expression and degradation of transgelin in myofibroblasts and keratinocytes are regulated by mechanical tension in cytoskeleton produced by myosin II motor in response to stiffness of culture matrix/extracellular matrix. PMID: 28898058
    5. transgelin (TAGLN), a transforming growth factor beta (TGFbeta)-inducible gene, was identified as an upregulated gene during in vitro osteoblastic and adipocytic differentiation of human bone marrow-derived stromal (skeletal) stem cells PMID: 27490926
    6. Smooth muscle 22 regulates the proliferation of aortic smooth muscle cells participates in the development of thoracic aortic dissection. PMID: 27320219
    7. regulates vasculogenic mimicry in breast cancer cells by enhancing interleukin-8 uptake PMID: 28058861
    8. Serum concentrations of CK-18 fragments and transgelin-2 correlate with the severity of NAFLD, but not with obesity. PMID: 27740519
    9. Increases or decreases in transgelin levels have reciprocal effects on tumor cell behavior, with higher expression promoting metastasis PMID: 26847345
    10. activated AKT and JNK signaling pathways promote the overexpression of transgelin PMID: 26694173
    11. Cofilin-1 and transgelin may play roles in the carcinogenesis and development of esophageal squamous cell carcinoma PMID: 26344167
    12. Both tissue and salivary transgelin mRNA were closely correlated with various important clinicopathological parameters and were independent prognosis factors for oral squamous cell carcinoma. PMID: 26242444
    13. SM22alpha is a phosphorylation-regulated suppressor of IKK-IkappaBalpha-NF-kappaB signaling cascades. PMID: 25937534
    14. EZH2 regulates the chromatin structure at the TAGLN promoter through tri-methylation of H3K27, acting as an epigenetic integrator of IL-1beta and TGFbeta2 signaling. PMID: 25917318
    15. Transgelin may be an excellent diagnostic marker of Triple negative tumors and could be useful in stratification of patients PMID: 25841305
    16. Results indicate that miR-144 may regulate osteosarcoma cell proliferation and invasion by downregulating its target gene, transgelin protein (TAGLN), suggesting that miR-144 may be a potential therapeutic target for the treatment of osteosarcoma. PMID: 25318625
    17. TAGLN was highly expressed in NF1-deficient malignant peripheral nerve sheath tumors compared to NF1-deficient plexiform neurofibromas. Upregulation was caused by increased transcriptional expression. The TAGLN gene was hypomethylated in the MPNST cells. PMID: 25109740
    18. our data suggest that TAGLN may be a viable therapeutic target and a potential biomarker for predicting the prognosis of patients with lung adenocarcinoma. PMID: 24938684
    19. The expression and biological role of transgelin seem to differ among various types of tumor cells and stroma, and possibly change during tumor progression. PMID: 24476357
    20. They also antagonized the TGF-beta1 induced up-regulation of CTGF and transgelin. PMID: 24828686
    21. Downregulated proteins in gallbladder cancer included serine protease HTRA1 and transgelin, which have been reported to be downregulated in several other cancers. PMID: 24657443
    22. HIF-2alpha upregulates transgelin indirectly and accumulated TGF-beta1 is a mediator in the upregulation of transgelin by HIF-2alpha under hypoxia. PMID: 24464808
    23. In leiomyosarcomas versus all other sarcomas transgelin emerged as the best diagnostic marker PMID: 23174934
    24. Expression of SM22 is inhibited in human CRC, and SM22 may act as a positive regulator of the processes of autophagy. PMID: 23538046
    25. Our results indicate that transgelin plays a promoting role in tumor progression, and appears to be a novel prognostic marker for advanced pancreatic cancer. PMID: 23331552
    26. the expressions of TAGLN were significantly reduced in colorectal carcinoma tissues and cells, and overexpression of TAGLN could decrease the proliferation and invasion and increase the apoptosis of LoVo cells PMID: 23138394
    27. COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. PMID: 22365974
    28. Depletion of SM22 could contribute to tumourigenic properties of cells. Reduction in SM22 would tend to promote cell survival when cells are under hypoxic stress, and may also contribute to increases in actin dynamics that favour metastatic potential. PMID: 22257561
    29. Strong transgelin expression is observed in renal tissue of patients with glomerulonephritis; its distribution is comparable to that of alpha-smooth muscle actin (alpha-SMA), a marker of myofibroblast activation in the kidney. PMID: 21677441
    30. SM22alpha overexpression enhances tumor cell growth and activates the IGF1R/PI3K/Akt pathway via direct interaction with IGF1Rbeta. PMID: 22245152
    31. The expression of Transgelin in the uterine body smooth muscle tissue of pregnant women during labor was higher than in non-labor. PMID: 21051832
    32. We found an increased expression of the TAGLN gene in endometriotic lesions compared with the eutopic endometrium of the same patients by real-time polymerase chain reaction. PMID: 21763649
    33. Down-regulation of SM22alpha in breast cancer is correlated with lymph node metastasis. PMID: 21092460
    34. Results indicate that the metastatic potential of CSCs arises from highly expressed Transgelin. PMID: 20707403
    35. these findings provide the first demonstration that SM22alpha modulates cellular senescence caused by damaging agents via regulation of the p16(INK4a)/pRB pathway in HepG2 cells and that these effects of SM22alpha are partially mediated by MT-1G. PMID: 20705054
    36. Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer PMID: 20012321
    37. Loss of SM22 is a molecular signature of colon cancer and is closely associated with progression, differentiation, and metastasis of colon cancer. PMID: 20336793
    38. results are indicative of p53-mediated mitochondria-associated apoptotic effects of transgelin on LNCaP cells in addition to its known suppressive effects on the AR pathway PMID: 20098441
    39. in pulmonary adenocarcinoma, overexpression of TAGLN was strictly localized to the tumor-induced reactive myofibroblastic stromal tissue compartment, whereas overexpression of TAGLN2 was exclusively localized to the neoplastic glandular compartment PMID: 19848416
    40. loss of transgelin gene expression may be an important early event in tumor progression and a diagnostic marker for breast and colon cancer development. PMID: 11773051
    41. Transgelin functions as a suppressor to inhibit prostate cancer cell growth PMID: 17082327
    42. crystallization and X-ray diffraction of transgelin. PMID: 17305610
    43. SM22 expression in SMCs was dramatically higher than in GC cells, which indicates that SM22 is unlikely to be a proper biomarker for GC. PMID: 17629319
    44. tagln is a novel target of TGF-beta/Smad3-dependent gene expression in alveolar epithelial type II cells PMID: 18245174
    45. 2.3 A resolution crystal structure of full length human transgelin, whose main structural feature is confirmed to be a CH domain. PMID: 18291675
    46. acts as a tumour suppressor; expression is lost in prostate, breast and colon cancers PMID: 18378184
    47. Identificaton of transgelin a novel biomarker for gastric adenocarcinoma. PMID: 18446369
    48. Selective overexpression of airway smooth muscle genes in asthmatic airways leads to increased Vmax, thus contributing to the airway hyperresponsiveness observed in asthma. PMID: 19011151
    49. Transgelin was expressed in pulmonary artery smooth myocytes under hypoxia compared with normoxia via and HIF-1alpha-independent pathway. Reducting transgelin expression by RNA interference impaired migration especially under hypoxia. PMID: 19188659
    50. Loss of transgelin involves gene promoter hypermethylation and is closely associated with poor overall survival in colorectal cancer patients. PMID: 19329940

    顯示更多

    收起更多

  • 亞細(xì)胞定位：
    Cytoplasm.
  • 蛋白家族：
    Calponin family
  • 數(shù)據(jù)庫(kù)鏈接：

    HGNC: 11553

    OMIM: 600818

    KEGG: hsa:6876

    STRING: 9606.ENSP00000278968

    UniGene: Hs.410977